Roughly two weeks after the referral was sent in by my oncologist, I had an hour long telephone appointment regarding genetic testing with one of the genetic counsellors at the Hereditary Cancer Program. She asked me if I understood what genetic testing was and the possible outcomes if I tested positive for one of the gene mutations. My oncologist had already explained to me that if I tested positive, recommendations for risk-reducing surgery would likely be put in place which may include a bilateral mastectomy (removal of both breasts) and oopherectomy (removal of the ovaries). It was a scary thought but at the same time was relieving knowing I had options out there to possibly prevent recurrence or development of other cancers.
The genetic counsellor then went into my family history of cancer. We spoke first about my dad’s side of the family which didn’t cause much concern in terms of having a hereditary risk. My great uncle had passed away from brain cancer in his 80s and my aunt had passed away from lung cancer in her 40s. My mom’s side of the family was where the red flags went up though. There was a lot of cancer, including multiples of particular types, and a few of us had also been diagnosed at a fairly young age. My great grandmother had passed away from pancreatic cancer in her 70s, my grandmother had passed away from breast cancer which metastasized to her bones later on in her 70s, my uncle had battled leukemia in his 40s and later passed away from another primary cancer in his 50s, and my cousin was currently battling pancreatic cancer which had spread to her liver in her late 30s. I was diagnosed with breast cancer at age 34.
There are certain referral criteria that must be met in order to qualify for genetic testing. These include having multiples of hereditary cancers such as breast, ovarian and colon cancers in close relatives, or being diagnosed with a hereditary cancer at a young age. Being under 35 and diagnosed with breast cancer, I was eligible to get tested for the 14 gene mutation panel, including the BRCA1, BRCA2, and TP53 gene mutations. Women with a BRCA1 or BRCA2 gene mutation have a 60% chance of developing breast cancer in their lifetime and also have a heightened risk of developing ovarian cancer. Whereas, a TP53 mutation increases a person’s risk of developing multiple cancers including leukemia, breast, ovarian, pancreatic, bone, and brain cancers. This mutation is a lot rarer to find in people than the BRCA1 + 2 but it was worth testing for given the extensive history of cancer in my family.